natgillin/translations-raw huggingface dataset:
If applicable, include the relevant certificate(s) of conformity of the online collection system with Regulation (EU) No 211/2011 of the European Parliament and of the Council of 16 February 2011 on the citizens’ initiative.)
Po potrebi priložite ustrezna potrdila, ki potrjujejo, da sistem spletnega zbiranja izpolnjuje pogoje iz Uredbe (EU) št. 211/2011 Evropskega parlamenta in Sveta z dne 16. februarja 2011 o državljanski pobudi)
Date and signature of the contact persons:
Datum in podpis kontaktnih oseb:
CERTIFICATE CONFIRMING THE NUMBER OF VALID STATEMENTS OF SUPPORT COLLECTED FOR … (NAME OF MEMBER STATE)
POTRDILO O ŠTEVILU VELJAVNIH IZJAV O PODPORI, ZBRANIH ZA …. (IME DRŽAVE ČLANICE)
(name of competent authority) of … (name of Member State), having made the necessary verifications required by Article 8 of Regulation (EU) No 211/2011 of the European Parliament and of the Council of 16 February 2011 on the citizens’ initiative, hereby certifies that … statements of support for the proposed citizens’ initiative having the registration number … are valid in accordance with the provisions of that Regulation.
(ime pristojnega organa) iz … (ime države članice) po opravljenem ustreznem preverjanju iz člena 8 Uredbe (EU) št. 211/2011 Evropskega parlamenta in Sveta z dne 16. februarja 2011 o državljanski pobudi potrjuje, da je … izjav o podpori predlagane državljanske pobude z evidenčno številko … veljavnih v skladu z določbami navedene uredbe.
FORM FOR THE SUBMISSION OF A CITIZENS’ INITIATIVE TO THE COMMISSION
OBRAZEC ZA PREDLOŽITEV DRŽAVLJANSKE POBUDE KOMISIJI
Title of citizens’ initiative:
Naslov državljanske pobude:
Number of valid statements of support received (must be at least one million):
Število prejetih veljavnih izjav o podpori: (mora biti najmanj milijon)
Number of signatories certified by Member States:
Število podpisnikov, ki so jih potrdile države članice:
Number of signatories
Število podpisnikov
Full names, postal addresses and e-mail addresses of the contact persons [1].
Polna imena, poštni naslovi in elektronski poštni naslovi kontaktnih oseb [1]:
Indicate all sources of support and funding received for the initiative, including the amount of financial support at the time of submission [1] Privacy statement: in accordance with Article 11 of Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data, data subjects are informed that these personal data are compiled by the Commission for the purpose of the procedure in respect of the citizens’ initiative.
Navedba vseh virov podpore in financiranja pobude, vključno z višino finančne podpore v času predložitve [1] Izjava o varstvu osebnih podatkov: v skladu s členom 11 Uredbe (ES) št. 45/2001 Evropskega parlamenta in Sveta z dne 18. decembra 2000 o varstvu posameznikov pri obdelavi osebnih podatkov v institucijah in organih Skupnosti in o prostem pretoku takih podatkov so posamezniki, na katere se osebni podatki nanašajo, obveščeni, da Komisija zbira te osebne podatke v okviru postopka v zvezi z državljansko pobudo.
We hereby declare that the information provided in this form is correct.
Izjavljamo, da so podatki na tem obrazcu pravilni.
(Include all certificates)
(Dodajte vsa potrdila)
Privacy statement: in accordance with Article 11 of Regulation (EC) No 45/2001 of the European Parliament and of the Council of 18 December 2000 on the protection of individuals with regard to the processing of personal data by the Community institutions and bodies and on the free movement of such data, data subjects are informed that these personal data are compiled by the Commission for the purpose of the procedure in respect of the citizens’ initiative.
Izjava o varstvu osebnih podatkov: v skladu s členom 11 Uredbe (ES) št. 45/2001 Evropskega parlamenta in Sveta z dne 18. decembra 2000 o varstvu posameznikov pri obdelavi osebnih podatkov v institucijah in organih Skupnosti in o prostem pretoku takih podatkov so posamezniki, na katere se osebni podatki nanašajo, obveščeni, da Komisija zbira te osebne podatke v okviru postopka v zvezi z državljansko pobudo.
Commission Regulation (EU) No 212/2011
Uredba Komisije (EU) št. 212/2011
concerning the authorisation of Pediococcus acidilactici CNCM MA 18/5M as a feed additive for laying hens (holder of authorisation Lallemand SAS)
o izdaji dovoljenja za Pediococcus acidilactici CNCM MA 18/5M kot krmni dodatek za kokoši nesnice (imetnik dovoljenja Lallemand SAS)
In accordance with Article 7 of Regulation (EC) No 1831/2003, an application was submitted for the authorisation of Pediococcus acidilactici CNCM MA 18/5M.
V skladu s členom 7 Uredbe (ES) št. 1831/2003 je bil vložen zahtevek za izdajo dovoljenja za Pediococcus acidilactici CNCM MA 18/5M.
The application concerns the authorisation of a new use of Pediococcus acidilactici CNCM MA 18/5M as a feed additive for laying hens, to be classified in the additive category ‘zootechnical additives’.
Zahtevek zadeva izdajo dovoljenja za Pediococcus acidilactici CNCM MA 18/5M kot krmni dodatek za kokoši nesnice in njegovo uvrstitev v kategorijo dodatkov „zootehnični dodatki“.
The use of Pediococcus acidilactici CNCM MA 18/5M was authorised without a time limit for chickens for fattening by Commission Regulation (EC) No 1200/2005 [2], without a time limit for pigs for fattening by Commission Regulation (EC) No 2036/2005 [3] and for 10 years for salmonids and shrimps by Commission Regulation (EC) No 911/2009 [4] and for weaned piglets by Commission Regulation (EU) No 1120/2010 [5].
Uporaba Pediococcus acidilactici CNCM MA 18/5M je bila brez časovne omejitve dovoljena za piščance za pitanje z Uredbo Komisije (ES) št. 1200/2005 [2] in za prašiče za pitanje z Uredbo Komisije (ES) št. 2036/2005 [3], za deset let pa za salmonide in kozice z Uredbo Komisije (ES) št. 911/2009 [4] ter za odstavljene pujske z Uredbo Komisije (ES) št. 1120/2010 [5].
New data were submitted in support of the application for the authorisation of Pediococcus acidilactici CNCM MA 18/5M for laying hens.
Predloženi so bili novi podatki v podporo zahtevku za izdajo dovoljenja za Pediococcus acidilactici CNCM MA 18/5M za kokoši nesnice.
The European Food Safety Authority (‘the Authority’) concluded in its opinion of 5 October 2010 [6] that Pediococcus acidilactici CNCM MA 18/5M, under the proposed conditions of use, does not have an adverse effect on animal health, human health or the environment, and that its use significantly increased the laying intensity of the target species.
Evropska agencija za varnost hrane (v nadaljnjem besedilu: Agencija) je v mnenju z dne 5. oktobra 2010 [6] navedla, da Pediococcus acidilactici CNCM MA 18/5M pod predlaganimi pogoji uporabe nima škodljivega vpliva na zdravje živali in ljudi ali okolje ter da njegova uporaba občutno povečuje nesnost ciljne živalske vrste.
Preparation of Pediococcus acidilactici CNCM MA 18/5M containing a minimum of 1 × 1010 CFU/g
Pripravek Pediococcus acidilactici CNCM MA 18/5M z vsebnostjo najmanj 1 × 1010 CFU/g dodatka
Viable cells of Pediococcus acidilactici CNCM MA 18/5 M
Žive celice Pediococcus acidilactici CNCM MA 18/5M
Analytical methods [1]Enumeration: spread plate method using MSR agar (EN 15786:2009)
Analitske metode [1]Metoda štetja: na razliti plošči z uporabo agarja MRS (EN 15786:2009)
Identification: Pulsed Field Gel Electrophoresis (PFGE)
Identifikacija: gelska elektroforeza v utripajočem polju (PFGE)
24 March 2021
24. marec 2021
Commission Regulation (EU) No 213/2011
Uredba Komisije (EU) št. 213/2011
amending Annexes II and V to Directive 2005/36/EC of the European Parliament and of the Council on the recognition of professional qualifications
o spremembi prilog II in V k Direktivi Evropskega parlamenta in Sveta 2005/36/ES o priznavanju poklicnih kvalifikacij
Having regard to Directive 2005/36/EC of the European Parliament and of the Council of 7 September 2005 on the recognition of professional qualifications [1], and in particular the second paragraph of Article 11 and the second paragraph of Article 26,
ob upoštevanju Direktive Evropskega parlamenta in Sveta 2005/36/ES z dne 7. septembra 2005 o priznavanju poklicnih kvalifikacij [1] in zlasti drugega odstavka člena 11 ter drugega odstavka člena 26,
Austria has requested the insertion in Annex II to Directive 2005/36/EC of 10 training programmes related to healthcare.
Avstrija je zaprosila, da se v Prilogo II k Direktivi 2005/36/ES vključi deset programov usposabljanja za zdravstveno nego.
These training programmes are regulated by the Healthcare and Nursing Special Task Ordinance (GuK-SV BGBl II No 452/2005) and the Healthcare and Nursing Teaching and Management Duties Ordinance (GuK-LFV BGBl II No 453/2005).
Te programe usposabljanja ureja Odlok o posebnih nalogah v zdravstveni negi in oskrbi (GuK-SV BGBl II št. 452/2005) ter Odlok o nalogah usposabljanja in upravljanja v zdravstveni negi in oskrbi (GuK-LFV BGBl II št. 453/2005).
As these Austrian training programmes are of an equivalent level of training to that provided for under Article 11(c)(i) of Directive 2005/36/EC and provide a comparable professional standard and prepare the trainee for a comparable level of responsibilities and functions, their inclusion on the basis of Article 11(c)(ii) in Annex II to Directive 2005/36/EC is justified.
Ker ti avstrijski programi ponujajo raven usposabljanja, enakovredno tisti, določeni s členom 11(c)(i) Direktive 2005/36/ES, ki zagotavlja primerljiv poklicni standard in udeleženca usposabljanja pripravi za primerljivo raven odgovornosti in nalog, je na podlagi člena 11(c)(ii) upravičena njihova vključitev v Prilogo II k Direktivi 2005/36/ES.
Portugal has submitted a reasoned request to include in point 5.1.3 of Annex V to Directive 2005/36/EC specialist medical training in medical oncology.
Portugalska je poslala utemeljeno zahtevo, da se pod točko 5.1.3 Priloge V k Direktivi 2005/36/ES vključi specialistično medicinsko usposabljanje za internistično onkologijo.
Medical oncology aims at offering a systemic treatment of cancer.
Cilj internistične onkologije je zagotoviti sistemsko zdravljenje raka.
The treatment of cancer patients has undergone major changes over the last decade due to scientific progress.
Zdravljenje bolnikov z rakom se je v zadnjem desetletju zaradi znanstvenega napredka zelo spremenilo.
Specialist medical training in medical oncology is not listed in point 5.1.3 of Annex V to Directive 2005/36/EC.
Specialističnega medicinskega usposabljanja za internistično onkologijo ni na seznamu v točki 5.1.3 Priloge V k Direktivi 2005/36/ES.
However, medical oncology has developed into a separate and distinct specialist medical training in more than two fifths of the Member States, which justifies its inclusion into point 5.1.3 of Annex V to Directive 2005/36/EC.
Vendar se je internistična onkologija v več kot dveh petinah držav članic razvila v področje z ločenim in posebnim specialističnim medicinskim usposabljanjem, kar upravičuje njeno vključitev v točko 5.1.3 Priloge V k Direktivi 2005/36/ES.
In order to ensure a sufficiently high level of specialist medical training, the minimum period of training required for the medical specialty of medical oncology to be automatically recognised should be five years.
Da se zagotovi zadovoljivo visoka raven specialističnega medicinskega usposabljanja, mora obdobje usposabljanja, ki je potrebno za avtomatično priznanje medicinske specializacije v internistični onkologiji, trajati najmanj 5 let.
France has submitted a reasoned request to include in point 5.1.3 of Annex V to Directive 2005/36/EC specialist medical training in medical genetics.
Francija je poslala utemeljeno zahtevo, da se pod točko 5.1.3 Priloge V k Direktivi 2005/36/ES vključi specialistično medicinsko usposabljanje za klinično genetiko.
Medical genetics is a specialty that responds to the rapid development of knowledge in the field of genetics and its implication in numerous specialised fields, such as oncology, foetal medicine, paediatrics, chronic diseases.
Klinična genetika je specializirano področje, ki mora spremljati hiter razvoj znanosti na področju genetike in njegove posledice za številna specializirana področja, kot so onkologija, fetalna medicina, pediatrija in kronične bolezni.
Medical genetics plays a growing role in screening and in the prevention of numerous pathologies.
Vse pomembnejša je tudi vloga klinične genetike pri odkrivanju in preprečevanju številnih patologij.
Specialist medical training in medical genetics is not listed in point 5.1.3 of Annex V to Directive 2005/36/EC.
Specialističnega medicinskega usposabljanja za klinično genetiko ni na seznamu v točki 5.1.3 Priloge V k Direktivi 2005/36/ES.
However, it has developed into a separate and distinct specialist medical training in more than two fifths of the Member States, which justifies its inclusion into point 5.1.3 of Annex V to Directive 2005/36/EC.
Vendar se je klinična genetika v več kot dveh petinah držav članic razvila v področje z ločenim in posebnim specialističnim medicinskim usposabljanjem, kar upravičuje njeno vključitev v točko 5.1.3 Priloge V k Direktivi 2005/36/ES.
In order to ensure a sufficiently high level of specialist medical training, the minimum period of training required for the medical specialty of medical genetics to be automatically recognised should be four years.
Da se zagotovi zadovoljivo visoka raven specialističnega medicinskega usposabljanja, mora obdobje usposabljanja, ki je potrebno za avtomatično priznanje medicinske specializacije v klinični genetiki, trajati najmanj 4 leta.
Directive 2005/36/EC should therefore be amended accordingly.
Direktivo 2005/36/ES je zato treba ustrezno spremeniti.
The measures provided for in this Regulation are in accordance with the opinion of the Committee on the Recognition of Professional Qualifications,
Ukrepi, predvideni s to uredbo, so v skladu z mnenjem Odbora za priznavanje poklicnih kvalifikacij –
Annexes II and V to Directive 2005/36/EC are amended as set out in the Annex to this Regulation.
Prilogi II in V k Direktivi 2005/36/ES se spremenita, kakor je določeno v Prilogi k tej uredbi.
Annexes II and V to Directive 2005/36/EC are amended as follows:
Prilogi II in V k Direktivi 2005/36/ES se spremenita:
in point 1 of Annex II, under ‘in Austria’, the following is added:
V točki 1 Priloge II se pod „v Avstriji“ doda naslednje besedilo:
special training in the care of children and young people (Sonderausbildung in der Kinder- und Jugendlichenpflege),
posebno usposabljanje za nego otrok in mladine (Sonderausbildung in der Kinder- und Jugendlichenpflege),
special training in psychiatric healthcare and nursing (Sonderausbildung in der psychiatrischen Gesundheits- und Krankenpflege),
posebno usposabljanje za psihiatrično zdravstveno nego in oskrbo (Sonderausbildung in der psychiatrischen Gesundheits- und Krankenpflege),
special training in intensive care (Sonderausbildung in der Intensivpflege),
posebno usposabljanje za intenzivno nego (Sonderausbildung in der Intensivpflege),
special training in intensive care of children (Sonderausbildung in der Kinderintensivpflege),
posebno usposabljanje za intenzivno nego otrok (Sonderausbildung in der Kinderintensivpflege),
special training in anaesthesia-related nursing (Sonderausbildung in der Anästhesiepflege),
posebno usposabljanje za nego pri anesteziji (Sonderausbildung in der Anästhesiepflege),
special training in renal replacement therapy related nursing (Sonderausbildung in der Pflege bei Nierenersatztherapie),
posebno usposabljanje za nego pri terapiji ob presaditvi ledvic (Sonderausbildung in der Pflege bei Nierenersatztherapie),
special training in operating department nursing (Sonderausbildung in der Pflege im Operationsbereich),
posebno usposabljanje za nego na operacijskem področju (Sonderausbildung in der Pflege im Operationsbereich),
special training in hospital hygiene (Sonderausbildung in der Krankenhaushygiene),
posebno usposabljanje za bolnišnično higieno (Sonderausbildung in der Krankenhaushygiene),
special training for teaching tasks in healthcare and nursing (Sonderausbildung für Lehraufgaben in der Gesundheits- und Krankenpflege),
posebno usposabljanje za naloge izobraževanja v zdravstveni oskrbi in negi (Sonderausbildung für Lehraufgaben in der Gesundheits- und Krankenpflege),
special training for management tasks in healthcare and nursing. (Sonderausbildung für Führungsaufgaben in der Gesundheits- und Krankenpflege),
posebno usposabljanje za naloge upravljanja v zdravstveni oskrbi in negi (Sonderausbildung für Führungsaufgaben in der Gesundheits- und Krankenpflege),
which represents education and training courses of a total duration of at least 13 years and six months to 14 years, including at least 10 years’ general education, a further three years’ basic training in the upper-grade public service for healthcare and nursing, and six to 12 months’ special training in a specialised, teaching or management task.’;
kar predstavlja tečaje izobraževanja in usposabljanja, ki trajajo skupno najmanj trinajst let in šest mesecev do štirinajst let, pri čemer je vsaj deset let splošnega izobraževanja, dodatna tri leta osnovnega višješolskega izobraževanja za javne storitve zdravstvene nege in oskrbe ter šest do dvanajst mesecev posebnega usposabljanja za specializirano nalogo ali nalogo izobraževanja ali upravljanja.“
the following table is added to point 5.1.3 of Annex V:
Točki 5.1.3 Priloge V se doda naslednja tabela:
Commission Regulation (EU) No 214/2011
Uredba Komisije (EU) št. 214/2011
amending Annexes I and V to Regulation (EC) No 689/2008 of the European Parliament and of the Council concerning the export and import of dangerous chemicals
o spremembi Prilog I in V k Uredbi (ES) št. 689/2008 Evropskega parlamenta in Sveta o izvozu in uvozu nevarnih kemikalij
Regulation (EC) No 689/2008 implements the Rotterdam Convention on the Prior Informed Consent Procedure for certain hazardous chemicals and pesticides in international trade, signed on 11 September 1998 and approved, on behalf of the Community, by Council Decision 2003/106/EC [2].
Uredba (ES) št. 689/2008 določa izvajanje Rotterdamske konvencije o postopku soglasja po predhodnem obveščanju za določene nevarne kemikalije in pesticide v mednarodni trgovini, ki je bila podpisana 11. septembra 1998 in odobrena v imenu Skupnosti s Sklepom Sveta 2003/106/ES [2].
Annex I to Regulation (EC) No 689/2008 should be amended to take into account regulatory action in respect of certain chemicals taken pursuant to Council Directive 91/414/EEC of 15 July 1991 concerning the placing of plant protection products on the market [3], Directive 98/8/EC of the European Parliament and of the Council of 16 February 1998 concerning the placing of biocidal products on the market [4] and Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the registration, evaluation, authorisation and restriction of chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC [5].
Prilogo I k Uredbi (ES) št. 689/2008 je treba spremeniti, da bi se upoštevali ureditveni ukrepi za nekatere kemikalije, sprejeti v skladu z Direktivo Sveta 91/414/EGS z dne 15. julija 1991 o dajanju fitofarmacevtskih sredstev v promet [3], Direktivo 98/8/ES Evropskega parlamenta in Sveta z dne 16. februarja 1998 o dajanju biocidnih pripravkov v promet [4] in Uredbo (ES) št. 1907/2006 Evropskega Parlamenta in Sveta z dne 18. decembra 2006 o registraciji, evalvaciji, avtorizaciji in omejevanju kemikalij (REACH) ter o ustanovitvi Evropske agencije za kemikalije in o spremembi Direktive 1999/45/ES ter razveljavitvi Uredbe Sveta (EGS) št. 793/93 in Uredbe Komisije (ES) št. 1488/94 ter Direktive Sveta 76/769/EGS in direktiv Komisije 91/155/EGS, 93/67/EGS, 93/105/ES in 2000/21/ES [5].
Annex V to Regulation (EC) No 689/2008 should be amended to take into account decisions taken in respect of certain chemicals under the Stockholm Convention on persistant organic pollutants (the Stockholm Convention), signed on 22 May 2001 and approved, on behalf of the Community, by Council Decision 2006/507/EC [6] and subsequent regulatory action in respect of those chemicals taken pursuant to Regulation (EC) No 850/2004 of the European Parliament and of the Council of 29 April 2004 on persistent organic pollutants and amending Directive 79/117/EEC [7].
Prilogo V k Uredbi (ES) št. 689/2008 je treba spremeniti, da se upoštevajo sklepi, ki so bile sprejeti za določene kemikalije v okviru Stockholmske konvencije o obstojnih organskih onesnaževalih (Stockholmska konvencija), podpisana 22. maja 2001 in odobrena s strani Skupnosti s Sklepom Sveta 2006/507/ES [6], in nadaljnji regulativni ukrepi za te kemikalije, ki so bili sprejeti na podlagi Uredbe (ES) št. 850/2004 Evropskega parlamenta in Sveta z dne 29. aprila 2004 o obstojnih organskih onesnaževalih in spremembi Direktive 79/117/EGS [7].
Annex V should also be amended to reflect regulatory action taken to ban the export of certain chemicals other than persistent organic pollutants.
Tudi Prilogo V je treba spremeniti, da bo v njej upoštevan regulativni ukrep o prepovedi izvoza določenih kemikalij razen obstojnih organskih onesnaževal.
The substances diphenylamine, triazoxide and triflumuron have not been included as active substances in Annex I to Directive 91/414/EEC, with the effect that those active substances are banned for pesticide use and thus should be added to the lists of chemicals contained in Parts 1 and 2 of Annex I to Regulation (EC) No 689/2008.
Snovi difenilamin, triazoksid in triflumuron niso bile vključene kot aktivne snovi v Prilogo I k Direktivi 91/414/EGS in se tako ne smejo uporabljati kot pesticidi ter jih je treba dodati na seznama kemikalij iz dela 1 in 2 Priloge I k Uredbi (ES) št. 689/2008.
Since new applications were submitted that will require new decisions on inclusion in Annex I to Directive 91/414/EEC, the addition to the list of chemicals contained in Part 2 of Annex I to Regulation (EC) No 689/2008 should not be applied until the new decisions on the status of those chemicals are adopted.
Ker so bili vloženi novi zahtevki, zaradi katerih bo treba sprejeti nove sklepe o vključitvi v Prilogo I k Direktivi 91/414/EGS, se sklep o dodajanju teh aktivnih snovi na seznam kemikalij iz dela 2 Priloge I k Uredbi (ES) št. 689/2008 ne uporablja, dokler ne bo sprejet nov sklep o statusu teh kemikalij.
The substances bifenthrin and metam have not been included as active substances in Annex I to Directive 91/414/EEC; as far as Directive 98/8/EC is concerned those substances have been identified and notified for evaluation.
Snovi bifentrin in metilditiokarbaminska kislina nista bili vključeni kot aktivni snovi v Prilogo I k Direktivi 91/414/EGS; kar zadeva Direktivo 98/8/ES sta bili ti dve snovi že opredeljeni in priglašeni za presojo.
As a result bifenthrin and metam are severely restricted for pesticide use since the use of both substances is almost completely prohibited despite the fact that they may continue to be authorised by Member States until a decision under Directive 98/8/EC is taken.
Kot rezultat sta bifentrin in metilditiokarbaminska kislina strogo omejeni na uporabo kot pesticida, ker je uporaba obeh snovi skoraj popolnoma prepovedana, kljub dejstvu, da ju države članice lahko dovoljujejo dokler ni sprejeta odločitev na podlagi Direktive 98/8/ES.
It is therefore appropriate to add bifenthrin and metam to the list of chemicals contained in Parts 1 and 2 of Annex I to Regulation (EC) No 689/2008.
Zato je primerno, da se bifentrin in metilditiokarbaminska kislina dodata na seznam kemikalij iz dela 1 in 2 Priloge I k Uredbi (EC) št. 689/2008.